Literature DB >> 8394729

Molecular mechanisms of SR 4233-induced hepatocyte toxicity under aerobic versus hypoxic conditions.

J M Silva1, P J O'Brien.   

Abstract

SR 4233 (3-amino-1,2,4-benzotriazine-1,4-dioxide) is the lead compound of the benzotriazene-di-N oxides which are selectively toxic to tumour cells under hypoxic conditions. However much higher concentrations given to rats caused bone marrow toxicity and necrosis of the low oxygen Zone 3 part of the liver. In the following effects of SR 4233 on hepatocytes under hypoxic vs aerobic conditions have been compared. (1) SR 4233 did not affect hepatocyte viability (as determined by plasma membrane disruption) or glutathione levels under aerobic conditions. SR 4233 however induced cyanide-resistant respiration, an indicator of redox cycling mediated oxidative stress and became cytotoxic if hepatocyte catalase or glutathione reductase was inactivated. Glutathione oxidation occurred well before cytotoxicity ensued. Addition of ascorbate markedly enhanced SR 4233 cytotoxicity to these compromised hepatocytes. (2) In contrast, SR 4233 was highly toxic to hypoxic hepatocytes. Addition of ascorbate to enhance SR 4233 reduction also caused a marked increase in hepatocyte toxicity and an SR 4233 radical was detected with ESR spectroscopy. SR 4233 cellular reduction and toxicity was prevented with fructose or inhibitors of NADPH:cytochrome P-450 reductase. Inactivation of catalase or glutathione reductase had no effect on SR 4233 toxicity and hepatocyte GSH was not oxidised indicating oxidative stress did not occur during hypoxic SR 4233 hepatocyte toxicity. (3) The lack of SR 4233 cytotoxicity under aerobic conditions could probably be attributed to the detoxification of the SR 4233 radical by mitochondrial oxidation as SR 4233, but not its metabolite SR 4317 markedly increased state III and IV mitochondrial respiration in the presence of NADH. The increased respiration was inhibited by the respiratory inhibitors KCN and antimycin A but not by rotenone. Furthermore SR 4233 cytotoxicity under aerobic conditions was markedly increased by partially inhibiting hepatocytes respiration with cyanide but not rotenone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394729      PMCID: PMC1968404          DOI: 10.1038/bjc.1993.374

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Proton movement accompanying monocarboxylate permeation in hemoglobin-free perfused rat liver.

Authors:  H Sies; G Noack
Journal:  FEBS Lett       Date:  1972-05-01       Impact factor: 4.124

2.  Assay of in situ radicals by electron spin resonance.

Authors:  R P Mason
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

3.  Isolation and use of liver cells.

Authors:  P Moldéus; J Högberg; S Orrenius
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

4.  High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides.

Authors:  D J Reed; J R Babson; P W Beatty; A E Brodie; W W Ellis; D W Potter
Journal:  Anal Biochem       Date:  1980-07-15       Impact factor: 3.365

5.  Acute lesions in rats caused by 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) or nitromin: a comparison with rates of reduction in microsomal systems from target organs.

Authors:  I N White; A Cahill; A Davies; P Carthew
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

6.  Structure-activity relationships for benzotriazine di-N-oxides.

Authors:  E M Zeman; M A Baker; M J Lemmon; C I Pearson; J A Adams; J M Brown; W W Lee; M Tracy
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-04       Impact factor: 7.038

7.  Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin.

Authors:  M I Walton; P Workman
Journal:  Biochem Pharmacol       Date:  1990-06-01       Impact factor: 5.858

8.  Selective inactivation of rat lung and liver microsomal NADPH-cytochrome c reductase by acrolein.

Authors:  J M Patel; E Ortiz; C Kolmstetter; K C Leibman
Journal:  Drug Metab Dispos       Date:  1984 Jul-Aug       Impact factor: 3.922

9.  Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H: (quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from Walker 256 rat tumour cells.

Authors:  R J Riley; P Workman
Journal:  Biochem Pharmacol       Date:  1992-01-22       Impact factor: 5.858

10.  Diaziquone-induced cytotoxicity in isolated rat hepatocytes.

Authors:  J M Silva; P J O'Brien
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701

View more
  8 in total

Review 1.  Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems.

Authors:  Alejandro Soto-Gutierrez; Albert Gough; Lawrence A Vernetti; D L Taylor; Satdarshan P Monga
Journal:  Exp Biol Med (Maywood)       Date:  2017-05-03

2.  Isotopic labeling experiments that elucidate the mechanism of DNA strand cleavage by the hypoxia-selective antitumor agent 1,2,4-benzotriazine 1,4-di-N-oxide.

Authors:  Xiulong Shen; Anuruddha Rajapakse; Fabio Gallazzi; Venkatraman Junnotula; Tarra Fuchs-Knotts; Rainer Glaser; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2013-12-19       Impact factor: 3.739

3.  Zinc finger nuclease knock-out of NADPH:cytochrome P450 oxidoreductase (POR) in human tumor cell lines demonstrates that hypoxia-activated prodrugs differ in POR dependence.

Authors:  Jiechuang Su; Yongchuan Gu; Frederik B Pruijn; Jeff B Smaill; Adam V Patterson; Christopher P Guise; William R Wilson
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

4.  Mechanisms of Antibacterial Action of Quinoxaline 1,4-di-N-oxides against Clostridium perfringens and Brachyspira hyodysenteriae.

Authors:  Fanfan Xu; Guyue Cheng; Haihong Hao; Yulian Wang; Xu Wang; Dongmei Chen; Dapeng Peng; Zhenli Liu; Zonghui Yuan; Menghong Dai
Journal:  Front Microbiol       Date:  2016-12-05       Impact factor: 5.640

5.  Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice.

Authors:  Yongchuan Gu; Tony T-A Chang; Jingli Wang; Jagdish K Jaiswal; David Edwards; Noel J Downes; H D Sarath Liyanage; Courtney R H Lynch; Frederik B Pruijn; Anthony J R Hickey; Michael P Hay; William R Wilson; Kevin O Hicks
Journal:  Front Pharmacol       Date:  2017-08-11       Impact factor: 5.810

6.  Kinetics of Flavoenzyme-Catalyzed Reduction of Tirapazamine Derivatives: Implications for Their Prooxidant Cytotoxicity.

Authors:  Aušra Nemeikaitė-Čėnienė; Jonas Šarlauskas; Violeta Jonušienė; Audronė Marozienė; Lina Misevičienė; Aliaksei V Yantsevich; Narimantas Čėnas
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

7.  Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.

Authors:  B G Siim; P L van Zijl; J M Brown
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

8.  Molecular mechanisms of tirapazamine (SR 4233, Win 59075)-induced hepatocyte toxicity under low oxygen concentrations.

Authors:  S Khan; P J O'Brien
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.